Lijun Rong

Chicago Biosolutions, Inc.

NIH Rank #6555
  • R01 Holder
  • Early Career

NIH Funding · FY2024

Total Funding
$1.8M
Fiscal year 2024
Grants Awarded
2
Active NIH grants
National Rank
#6,555
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $1.8M across 2 grants · National rank #6555.

Top grants by award amount

Lijun Rong's NIH grant portfolio, ranked by award amount.

  • 5R42AI155039-04R42
    Development of 4-(aroylamino)piperidine-based entry inhibitors as anti-influenza therapeutics
    $999.2K
    award amount
  • 5R01AI168362-03R01
    Optimizing Ridaifen-B analogs as potential therapeutics for Ebola viruses
    $787.4K
    award amount

Affiliations

Institutions that have administered grants for Lijun Rong.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Chicago Biosolutions, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #6555
  5. 2024
    Multi-Institutional Research
    Awards at 2 institutions